elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - Антинеопластични средства - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
colivet premix
ceva sante animale france - Колистина сулфат - медикаментозен премикс - 12 g (246 000 000 ui) - зайци, пилета, прасета
colisys premix 10 g/100 g
sp veterinaria s.a - Колистин (сулфат) - премикс за медикаментозен фураж - 10 g/100 g - свине
colivet oral solution 2 miu/ml
ceva sante animale - Колистина сулфат - перорален разтвор - 2 miu/ml - прасета, птици
colivet Оral powder 1, 2 miu/g
ceva sante animale - Колистин (сулфат) - перорален прах - 1, 2 miu/g - прасета, птици, телета
hidrocol, 4000000 iu/ml solution for use in drinking water/milk 4 000 000 iu/ml
s.p. veterinaria s.a. - Колистин - разтвор за прилагане във вода за пиене/мляко - 4 000 000 iu/ml - агнета, пилета, прасета, пуйки, телета
promycine-4800 4 800 000 iu/g
v.m.d. nv - Колистина сулфат - перорален прах - 4 800 000 iu/g - прасета, телета
multibio d
virbac - ampicilline, колистин сулфат, Дексаметазона ацетат - инжекционна суспензия - 10 g/ 100 ml; 25 miu/100 ml; 25 mg/100 ml - говеда, свине
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - Антинеопластични средства - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - Лимфом, мантел-клетка - Антинеопластични средства - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).